Population
Patients with end-stage heart failure with reduced ejection fraction who have no other life-limiting diseases
Design
Review
Key result
Mechanical circulatory support with left ventricular assist devices significantly improves survival and quality of life in appropriately selected patients with end-stage heart failure.
Authors
Loading...
Supports LVAD consideration in end-stage HFrEF after evaluation; leaves open need for prospective trials to refine selection.
Left ventricular assist devices significantly improve survival and quality of life in patients with end-stage HFrEF and should be considered after thorough evaluation.
Birati et al. (2015) conducted a review in Advanced Heart Failure. Left Ventricular Assist Devices (LVAD) was evaluated. Mechanical circulatory support with left ventricular assist devices significantly improves survival and quality of life in appropriately selected patients with end-stage heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: